NASDAQ · Biotechnology

Jazz Pharmaceuticals plc (JAZZ) Stock

$218.42 -1.81% NASDAQ: JAZZ Healthcare

Valuation

MetricValue
Price$218.42
Market Cap$13.72B
P/E Ratio15.33
P/B Ratio3.07
P/S Ratio3.18
EPS (TTM)$-5.84
52-Week High$266.38
52-Week Low$128.80
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE21.37%
ROA8.49%
ROCE16.14%
Gross Margin84.12%
Operating Margin11.13%
Net Margin20.45%
Debt/Equity0.92
Current Ratio1.86

Annual Financials (USD)

Metric20212022202320242025
Revenue$3.1B$3.7B$3.8B$4.1B$4.3B
Operating Profit$170.0M$-66.0M$579.0M$717.0M$224.0M
Net Profit$-329.0M$-224.0M$415.0M$560.0M$-356.0M
EPS$-5.51$-3.58$6.10$8.65$-5.84
Op Margin5.5%-1.8%15.1%17.6%5.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$12.3B$10.8B$11.4B$12.0B$11.7B
Total Liabilities$8.3B$7.8B$7.7B$7.9B$7.3B
Cash$591.0M$881.0M$1.5B$2.4B$1.4B
Borrowings$6.2B$5.8B$5.8B$6.2B$5.4B

Latest News

JAZZ: Raising target price to $267.00 Argus Research · Jul 22, 2026 Will Jazz (JAZZ) Beat Estimates Again in Its Next Earnings Report? Zacks · Jul 21, 2026 Jazz Pharmaceuticals to Report Second Quarter Financial Results on August 3, 2026 PR Newswire · Jul 20, 2026 Jazz Pharmaceuticals (JAZZ) Stock Still Looks Like A Bargain After A 119% Run Simply Wall St. · Jul 18, 2026 Jazz Pharmaceuticals (JAZZ) Refocuses Its Sleep Franchise, Is The Stock Still Cheap? Simply Wall St. · Jul 18, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$779.0M$1.3B$1.1B$1.4B$1.4B
Investing Cash Flow$-5.3B$-944.0M$-187.0M$-556.0M$-1.7B
Financing Cash Flow$-36.0M$-45.0M$-321.0M$-375.0M$-200.0M
Net Cash Flow$-466.0M$290.0M$625.0M$907.0M$-1.0B
Free Cash Flow$733.0M$774.0M$1.1B$1.3B$1.1B

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA11.81
FCF Yield10.53%
Quick Ratio1.58
Interest Coverage7.35
Return 1Y68.04%
Return 3Y79.33%
Return 5Y66.95%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
GMABGenmab A/S $29.00 -2.62% 21.45 $17.80B 0.00%
HRMYHarmony Biosciences Holdings, Inc. $40.28 +1.72% 12.66 $2.33B 0.00%
INCYIncyte Corporation $112.79 +0.04% 15.15 $22.86B 0.00%
LEGNLegend Biotech Corporation $23.58 +0.17% -17.34 $4.36B 0.00%
LGNDLigand Pharmaceuticals Incorporated $301.81 +2.31% 31.21 $6.05B 0.00%

About Jazz Pharmaceuticals plc

Jazz Pharmaceuticals plc is led by CEO Renee D. Gala, employs 2,890 people, headquartered in Dublin, IE, publicly traded since 2007.

Jazz Pharmaceuticals plc (JAZZ) stock trades at $218.42 with a market capitalization of $13.72B. The stock is valued at a price-to-earnings (P/E) ratio of 15.33, price-to-book of 3.07, price-to-sales of 3.18. Over the past 52 weeks the stock has ranged between $128.80 and $266.38, and currently trades 18.0% below its 52-week high.

On profitability, Jazz Pharmaceuticals plc generates a return on equity (ROE) of 21.37% — well above the market average, a sign of a high-quality business, return on capital employed of 16.14%, an operating margin of 11.13%, a net profit margin of 20.45%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides